Evidence map›Paper›PMID 19046321›Full record

ArticleJournal of neurochemistry2009

Regions of the amino terminus of the P2X receptor required for modification by phorbol ester and mGluR1alpha receptors.

Hairuo Wen, Richard J Evans

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Regulation of P2X1 receptors by modulators of the cAMP effectors PKA and EPAC.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  2. CaThe Journal of biological chemistry · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The P2X1 receptor and platelet function.Purinergic signalling · 2011
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hairuo WenDepartment of Cell Physiology & Pharmacology, University of Leicester, Leicester, UK.
Richard J Evans
University of Leicester · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The potentiation of P2X(1) receptor currents by phorbol ester (PMA) treatment and stimulation of mGluR1alpha receptors was sensitive to inhibition of novel forms of protein kinase C. Potentiation was also reduced by co-expression of an amino terminal P2X(1) receptor minigene. Cysteine point mutants of residues Tyr(16)-Gly(30) were expressed in Xenopus oocytes. Peak current amplitudes to ATP for Y16C, T18C and R20C mutants were reduced, however this did not result from a decrease in surface expression of the channels. The majority of the mutants showed changes in the time-course of desensitization of ATP evoked currents indicating the important role of this region in regulation of channel properties. PMA and mGluR1alpha potentiation was abolished for the mutants Y16C, T18C, R20C, K27C and G30C. Minigenes incorporating either Y16C, K27C, V29C or G30C still inhibited PMA responses. However D17C, T18C or R20C mutant minigenes were no longer effective suggesting that these residues are important for interaction with regulatory factors. These results demonstrate that the conserved YXTXK/R sequence and a region with a conserved glycine residue close to the first transmembrane segment contribute to PMA and GPCR regulation of P2X(1) receptors.

Indexed as

Adenosine TriphosphateAnimalsCysteineElectric StimulationEnzyme InhibitorsGlutamic AcidHumansMembrane PotentialsMutagenesisOocytesPatch-Clamp TechniquesPeptide FragmentsPhorbol EstersReceptors, Metabotropic GlutamateReceptors, Purinergic P2Receptors, Purinergic P2X2Adenosine TriphosphateCysteineEnzyme InhibitorsGlutamic Acidmetabotropic glutamate receptor type 1P2RX2 protein, humanPeptide FragmentsPhorbol EstersReceptors, Metabotropic GlutamateReceptors, Purinergic P2Receptors, Purinergic P2X2

Identifiers

PMID19046321
PMCPMC2704932
OpenAlexW1990452733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.